New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareThymosin Beta-4 vs KPV

Thymosin Beta-4 vs KPV

Side-by-side comparison of key properties, dosing, and research.

Recovery & RepairAnti-Aging & Longevity
Thymosin Beta-4
Immune SupportRecovery & Repair
KPV
Summary
Thymosin Beta-4 is an endogenous 43-amino acid peptide that is the primary intracellular actin sequestering peptide. It promotes tissue repair, reduces inflammation, regenerates hair follicles, and protects cardiac tissue. Closely related to TB-500 (the active fragment), it is used for systemic tissue recovery and anti-aging.
KPV is a naturally occurring anti-inflammatory tripeptide derived from the C-terminal of alpha-MSH. It powerfully suppresses intestinal and systemic inflammation via melanocortin receptors, making it valuable for IBD, gut healing, and wound repair.
Half-Life
Not well characterized; likely similar to TB-500 (~1–2 hours)
Short half-life (~15–30 minutes), but effects persist longer due to receptor-level anti-inflammatory cascades
Admin Route
SubQ, IM
Oral, SubQ, Topical
Research
Typical Dose
5–10 mg
500 mcg – 1 mg
Frequency
2x per week (loading), then 1x per week (maintenance)
Once to twice daily
Key Benefits
  • Systemic tissue repair and regeneration
  • Promotes cardiac recovery after myocardial infarction
  • Hair follicle regeneration and anti-hair-loss
  • Anti-inflammatory (systemic)
  • Wound healing acceleration
  • Neuroprotection after brain injury
  • Protects against ischemia-reperfusion injury
  • Anti-aging at cellular level
  • Synergizes powerfully with BPC-157
  • Reduces intestinal inflammation (IBD, Crohn's, colitis)
  • Promotes gut mucosal healing and barrier integrity
  • Accelerates wound healing topically
  • Suppresses systemic inflammatory cytokines
  • Antimicrobial properties against pathogens
  • Reduces neuroinflammation when administered systemically
  • May improve symptoms of inflammatory skin conditions
Side Effects
  • Generally very well tolerated
  • Injection site reactions
  • Mild fatigue at initiation (repair signaling)
  • Rare: mild inflammatory response
  • +1 more
  • Generally very well tolerated
  • Mild injection site reactions (SC)
  • Rare: transient flushing
Stacks With